Concepedia

Sarah Martin

SM

Statistics

Publications

35

Citations

3.2K

H-Index

22

Active since

1985

Affiliations

University of Oxford(Current)

Canberra Hospital

Australian National University

Genomics (United Kingdom)

University of Canberra

Sarah Martin is an author at University of Oxford specializing in pharmacology, pharmacy, and bromodomain inhibition.

Publications per year

1985–2023

35

Publications

35

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain

S. Picaud, Christopher Wells, I. Felletar et al. · Proceedings of the National Academy of Sciences · 2013 · 481 citations · Full text

Life Sciences, Molecular Biology, Cell Signaling +11

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study

Andrew E. Grulich, Rebecca Guy, Janaki Amin et al. · The Lancet HIV · 2018 · 369 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +17

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

Pietro Ciceri, Susanne Müller, Alison O’Mahony et al. · Nature Chemical Biology · 2014 · 350 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains

Duncan A. Hay, Oleg Fedorov, Sarah Martin et al. · Journal of the American Chemical Society · 2014 · 285 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy

S. Picaud, O. Fedorov, Angeliki Thanasopoulou et al. · Cancer Research · 2015 · 230 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 35